Molecular Templates, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Redeemable Convertible Preferred Stock (Tables)

Redeemable Convertible Preferred Stock (Tables)

12 Months Ended

Dec. 31, 2017

Temporary Equity Disclosure [Abstract]

Summary of Redeemable Convertible Preferred Stock

The following is a summary of the Company’s redeemable convertible preferred stock at December 31, 2017 and 2016 (collectively, the “Preferred Stock”) (in thousands):

					Shares Issued and Outstanding
	Par Value		Shares Authorized		December 31, 2017		December 31, 2016
Series A Preferred Stock	$	0.001		2,500		—		2,500
Series B Preferred Stock	$	0.001		2,273		—		2,273
Series C Preferred Stock	$	0.001		4,392		—		4,343
Total				9,165		—		9,116

Schedule of Changes in the Preferred Stock

The following table presents changes in the preferred stock during the years ended December 31, 2017 and 2016 (in thousands):

	Series A Preferred			Series B Preferred			Series C Preferred			Total
Balance at December 31, 2015	$	3,689		$	5,174		$	15,436		$	24,299
Deemed dividends on preferred stock		200			306			1,066			1,572
Balance at December 31, 2016	$	3,889		$	5,480		$	16,502		$	25,871
Deemed dividends on preferred stock		119			178			661			958
Conversion to common stock in merger		(4,008	)		(5,658	)		(17,163	)		(26,829	)
Balance at December 31, 2017	$	—		$	—		$	—		$	—